HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

483.155

-13.603-2.74%

Number of Gainers:7

Number of Losers:23

Number of Flat:3

PE:- -

High:496.758

Open:496.758

Low:480.328

Close:496.758

Volume:115.32M

Turnover:2.61B

Market Cap:306.93B

Float Cap:273.30B

Loading ...

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Edding Genor Chairman to Boost Shareholding

MT Newswires Live

Pharmaceutical Agent Sentenced for Bribery After Profiting 1.47 Million and Returning 1.5 Million

MP CARDIOFLOW-B (02160) Trading Halt Scheduled From September 1st

Dizal's Sunvozertinib Licensing Deal with AstraZeneca Officially Takes Effect

Trump Administration’s Medicaid Drug Pricing Deal Set to Stir Asian Pharma Stocks

EDDING GENOR (06998) Spends HK$619,900 on Share Buyback on August 31

CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

Sweden's Klaria Net Loss Narrows on Lower R&D Expenses

Edding Genor Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 1.56 Avg Price

Sinomab Bioscience Posts HY Loss of Rmb127.4 Million

Acotec Scientific Posts HY Revenue of RMB 331.6 Million

Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million

China's United Laboratories Half-Year Profit Drops 82%

HEARTCARE-B Reports Strong 2026 Interim Results: Revenue Up 56.9% to RMB290 Million, Adjusted Net Profit Surges 105.9%

Jhbp Cy - Chairman and CEO NI Xin to Buy Shares up to USD 1 Mln from Aug 31, 2026

THOMSON REUTERS

SinoMab BioScience Ltd - Hy Loss Rmb127.4 Mln

THOMSON REUTERS

SinoMab FY26 H1 Loss Widens to RMB 127.4 Million; Funding Available Drops to RMB 196.5 Million

China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1574/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":483.15506,"timestamp":1789114133774,"preClose":496.75812,"halted":0,"volume":115323363,"delay":0,"changeRate":-0.027384,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.603058,"latestTime":"09-11 16:00:00","open":496.75812,"high":496.75812,"low":480.32812,"amount":2611810568,"amplitude":0.033074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.703217,"peRate":164.740195,"turnoverRate":0.004215,"increases":6,"decrements":25,"flats":1,"marketCap":306930068880,"floatMarketCap":273297591592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.033074,"preClose":496.75812,"low":480.32812,"pbRate":"3.703217","latestPrice":483.15506,"volume":115323363,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.004215,"peRate":164.740195,"marketCap":306930068880,"floatMarketCap":273297591592,"timestamp":1789114133774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":23,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100056289","title":"Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1100056289","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100056289?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:06","pubTimestamp":1788249995,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) announced that its wholly-owned subsidiary, Aviwe Bio-Tech Co., Ltd., has obtained the medical device registration certificate for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","HART","IEIH","AGNG","002086","RSPH","BK0092","MDEV","BK1100","BK1574","MEDX","LGHT","09996","BK0046","PTH","GDOC","159883","BK1583","BK0213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132713513","title":"Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=1132713513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132713513?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249011,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical giant Novartis AG (NVS.US) is experiencing a stark contrast in its neuro-immunology pipeline, as progress in one area is overshadowed by a serious setback in another. The company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","MEDX","LU0320765489.SGD","MDTX","IE00BJT1NW94.SGD","BK4585","BK1574","IBBQ","LU0211331839.USD","BMED","IE0002141913.USD","BK4532","BK4588","BK4578","IBBJ","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","NVS","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","PSYK","LU0208291251.USD","LU0070302665.USD","01477","BK4007","IE0009355771.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887351","title":"Edding Genor Chairman to Boost Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887351","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887351?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:38","pubTimestamp":1788230287,"startTime":"0","endTime":"0","summary":"Edding Genor Group Holdings  Chairman and CEO Ni Xin plans to spend up to $1 million to buy additional company shares, according to a Hong Kong Exchange filing on Monday.Ni will execute the open market share purchases using his personal funds.The biopharmaceutical company added that it has commenced its planned stock buyback, and the repurchased shares will be used for employee incentives, market capitalization management or other purposes, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105562547","title":"Pharmaceutical Agent Sentenced for Bribery After Profiting 1.47 Million and Returning 1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1105562547","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105562547?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:21","pubTimestamp":1788229261,"startTime":"0","endTime":"0","summary":"A pharmaceutical sales representative has been sentenced to prison for offering kickbacks to state personnel, according to a judgment recently made public on China Judgements Online.Court documents...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","159938","PRTO","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167267953","title":"MP CARDIOFLOW-B (02160) Trading Halt Scheduled From September 1st","url":"https://stock-news.laohu8.com/highlight/detail?id=1167267953","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167267953?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:58","pubTimestamp":1788224295,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) has announced that its shares will be suspended from trading starting at 9:00 a.m. today, September 1, 2026.The company issued an official statement confirming the temporary...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02160","BK1239","BK1583","02918","BK1574","BK1100","BK1225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176183367","title":"Dizal's Sunvozertinib Licensing Deal with AstraZeneca Officially Takes Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=1176183367","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176183367?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:50","pubTimestamp":1788223828,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co.,Ltd. (688192.SH) has announced that its exclusive licensing agreement with AstraZeneca UK Limited for the global development and commercialization of Sunvozertinib has...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","BK0239","688192","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169588395","title":"Trump Administration’s Medicaid Drug Pricing Deal Set to Stir Asian Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1169588395","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169588395?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:20","pubTimestamp":1788218431,"startTime":"0","endTime":"0","summary":"Shares of Asian pharmaceutical companies could see market movement following the Trump administration’s announcement of a new drug pricing agreement with nine biotech and pharmaceutical firms. Under...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XHS","01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143660951","title":"EDDING GENOR (06998) Spends HK$619,900 on Share Buyback on August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1143660951","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143660951?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:38","pubTimestamp":1788215890,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on August 31, 2026, the company allocated HK$619,900 to repurchase 397,500 of its own shares.This buyback activity reflects the company's ongoing capital...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882693","title":"CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882693","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882693?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:24","pubTimestamp":1788215066,"startTime":"0","endTime":"0","summary":"It's been a good week for CanSino Biologics Inc. ( HKG:6185 ) shareholders, because the company has just released its...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-just-missed-earnings-but-analysts-have","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/cansino-biologics-inc-just-missed-earnings-but-analysts-have","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06185","VOTE","BK1574","DECU","JOYT","VGFPF","BK1515","GXDW","BK1191","RGLO","BK1161","FEBU","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885193","title":"Sweden's Klaria Net Loss Narrows on Lower R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885193","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885193?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:08","pubTimestamp":1788214086,"startTime":"0","endTime":"0","summary":"Sweden's Klaria net loss narrows on lower R&D expensesOverviewSweden pharma developer reported no Q2 net sales, unchanged from prior yearQ2 net loss after tax narrowed year-over-year, with lower R&D e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S13U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01672","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664159885","title":"Edding Genor Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 1.56 Avg Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2664159885","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664159885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:06","pubTimestamp":1788213976,"startTime":"0","endTime":"0","summary":"Edding Genor files HKEX next-day disclosure return on share buyback at HKD 1.56 avg priceEdding Genor filed a next-day disclosure return reporting a repurchase of 397,500 shares on Aug. 31, held as tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9dVTP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881007","title":"Sinomab Bioscience Posts HY Loss of Rmb127.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881007","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881007?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:52","pubTimestamp":1788195169,"startTime":"0","endTime":"0","summary":"BRIEF-Sinomab Bioscience Posts HY Loss Of RMB127.4 MillionAug 31 (Reuters)-SinoMab BioScience Ltd3681.HK:HY LOSS RMB127.4 MILLIONFurther company coverage:3681.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664700229","title":"Acotec Scientific Posts HY Revenue of RMB 331.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664700229","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664700229?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:26","pubTimestamp":1788193602,"startTime":"0","endTime":"0","summary":"BRIEF-Acotec Scientific Posts HY Revenue Of RMB 331.6 MillionAug 31 (Reuters)-Acotec Scientific Holdings Limited6669.HK:HY REVENUE RMB 331.6 MILLIONHY LOSS RMB 80.8 MILLIONBOARD DOES RECOMMEND PAYMENT OF INTERIM DIVIDENDFurther company coverage:6669.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06669","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004431","title":"Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004431","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004431?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:21","pubTimestamp":1788189709,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 MillionAug 31 (Reuters)-Venus Medtech (Hangzhou) Inc2500.HK:SIX-MONTH REVENUE RMB135.5 MILLIONFurther company coverage:2500.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004932","title":"China's United Laboratories Half-Year Profit Drops 82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004932?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:11","pubTimestamp":1788189105,"startTime":"0","endTime":"0","summary":"China's United Laboratories half-year profit drops 82%OverviewChina pharmaceutical maker's half-year revenue fell 18% yr/yrNet income attributable to owners dropped 82% yr/yrCompany did not declare in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1191","BK1574","01672","IE00B3M56506.USD","00950","01228","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171415138","title":"HEARTCARE-B Reports Strong 2026 Interim Results: Revenue Up 56.9% to RMB290 Million, Adjusted Net Profit Surges 105.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171415138","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171415138?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:48","pubTimestamp":1788187703,"startTime":"0","endTime":"0","summary":"HEARTCARE-B (06609) released its interim results for the first half of 2026 on August 31. During the period, the company generated revenue of RMB290 million, marking a 56.9% year-on-year increase....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1100","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663119001","title":"Jhbp Cy - Chairman and CEO NI Xin to Buy Shares up to USD 1 Mln from Aug 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663119001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663119001?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:41","pubTimestamp":1788187276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001896","title":"SinoMab BioScience Ltd - Hy Loss Rmb127.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663001896?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:27","pubTimestamp":1788186426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001857","title":"SinoMab FY26 H1 Loss Widens to RMB 127.4 Million; Funding Available Drops to RMB 196.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001857","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663001857?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:25","pubTimestamp":1788186341,"startTime":"0","endTime":"0","summary":"SinoMab FY26 H1 loss widens to RMB 127.4 million; funding available drops to RMB 196.5 millionSinoMab posted a net loss of RMB 127.4 million for the six months ended June 30, 2026, versus RMB 49.8 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL5rZnp2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663966006","title":"China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2663966006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663966006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:31","pubTimestamp":1788183111,"startTime":"0","endTime":"0","summary":"China's Ascletis Pharma H1 net loss widens on higher R&D costsOverviewChina biopharma developer's interim net loss widened 263% yr/yr to RMB319.7 mlnTotal income for the period fell 49% yr/yrR&D expen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","01228","BK4551","BK1574","BK4535","BK4548","BNTX","BK1515","BK1161","BK4588","BK4139","01672","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":10,"totalSize":264,"code":"91000000","status":"200"}]}}